Laura Gragnani, Elisa Fognani, Alessia Piluso, Barbara Boldrini, Teresa Urraro, Alessio Fabbrizzi, Cristina Stasi, Jessica Ranieri, Monica Monti, Umberto Arena, Claudio Iannacone, Giacomo Laffi, Anna Linda Zignego, for the MaSVE Study Group – 27 November 2014 – Limited data are available about the efficacy of antiviral treatment in hepatitis C virus (HCV)–associated mixed cryoglobulinemia (MC), especially concerning the long‐term effects of HCV eradication.

Craig McClain – 27 November 2014

Diego F. Calvisi – 27 November 2014

Florence Wong, Wesley Leung, Mohammed Al Beshir, Max Marquez, Eberhard L. Renner – 25 November 2014 – Hepatorenal syndrome type 1 (HRS1) is acute renal failure in the setting of advanced cirrhosis, and it results from hemodynamic derangements, which should be fully reversible after liver transplantation. However, the rate of hepatorenal syndrome (HRS) reversal and factors predicting renal outcomes after transplantation have not been fully elucidated. The aim of this study was to assess outcomes of HRS1 patients after liver transplantation and factors predicting HRS reversal.

James O'Beirne – 25 November 2014

Elisabeth Krones, Wolfgang Erwa, Michael Trauner, Peter Fickert – 25 November 2014

Julia Szendroedi, Michael Roden – 25 November 2014

Cristiano Quintini, Mario Spaggiari, Koji Hashimoto, Federico Aucejo, Teresa Diago, Masato Fujiki, Charles Winans, Giuseppe D'Amico, Loris Trenti, Dympna Kelly, Bijan Eghtesad, Charles Miller – 25 November 2014 – The presence of portal vein thrombosis (PVT) is still considered by many transplantation centers to be an absolute contraindication to liver transplantation because of the technical difficulties that it can present and its association with a higher rate of patient morbidity and mortality. Renoportal bypass (RPB) can help to remove these barriers.

Isaac Ruiz, Cyrille Feray, Jean‐Michel Pawlotsky, Christophe Hézode – 25 November 2014

Naoya Yamada, Yukihiro Sanada, Yuta Hirata, Noriki Okada, Taiichi Wakiya, Yoshiyuki Ihara, Atsushi Miki, Yuji Kaneda, Hideki Sasanuma, Taizen Urahashi, Yasunaru Sakuma, Yoshikazu Yasuda, Koichi Mizuta – 25 November 2014 – In the field of pediatric living donor liver transplantation (LDLT), physicians sometimes must reduce the volume of left lateral segment (LLS) grafts to prevent large‐for‐size syndrome. There are 2 established methods for decreasing the size of an LLS graft: the use of a segment 2 (S2) monosegment graft and the use of a reduced LLS graft.